Target intelligence / Profile preview

MADD antisense RNA 1 (MADD-AS1)

Target
MADD-AS1
Molecular classification
long non-coding RNA, antisense RNA
01

Overview

MADD antisense RNA 1 (MADD-AS1) is a long non-coding RNA (lncRNA) transcribed from the opposite strand of or near the MADD gene locus. There are no peer-reviewed research publications directly characterizing the function, biological role, or disease association of MADD-AS1. Based on naming conventions and genomic annotation, it is presumed to be an antisense RNA that may be involved in transcriptional or post-transcriptional regulation of the MADD gene or neighboring genes, but there is currently no evidence it functions as a protein, receptor, enzyme, or druggable target[1]. There is no information about its therapeutic targeting, disease biomarker potential, drug interactions, or mechanisms of action in the literature. - MADD-AS1 is not a protein, receptor, transporter, enzyme, or established signaling pathway component. It is not a validated therapeutic target. - The existence and putative annotation as an antisense lncRNA may be correct, but supporting functional or biomedical data are lacking. - There is no evidence of misspelling, but there is insufficient information to establish meaningful structured data for downstream use in biomedical target databases.

Other names
MADD-AS1MADD antisense RNA 1
02

Mechanism of action

Not established

03

Biological functions

Unknown or not well characterizedgeneral potential for transcriptional regulation or gene expression modulation as with similar lncRNAs
04

Disease associations

Unknown

Beyond the preview

Go deeper on MADD antisense RNA 1 (MADD-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MADD antisense RNA 1 (MADD-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call